In view of these findings, it is possible to infer that NF-κB activation by NF-κB in poststroke patients may contribute not only to muscle atrophy, but also to endothelial dysfunction, causing a positive feedback, ROS production, and inflammation, while maintaining NF-κB activation. Here, NFKB1 is linked to endothelial dysfunction.